Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer.
Parmar S, Keck JM, Kong B, Look R, Johnson B, Patterson J, Labrie M, Guimaraes AR, Corless CL, Beadling C, Kolodzie A, Bergan R, Gray JW, Mills GB, Mitri ZI.
Parmar S, et al. Among authors: look r.
JCO Precis Oncol. 2021 Jan 8;5:PO.20.00183. doi: 10.1200/PO.20.00183. eCollection 2021.
JCO Precis Oncol. 2021.
PMID: 34250408
Free PMC article.
No abstract available.